A Case of Marrow Fibrosis with Megakaryocytic Hyperplasia after Short-Term use of Granulocyte Colony-Stimulating Factor

Clin Lab. 2023 Sep 1;69(9). doi: 10.7754/Clin.Lab.2023.230345.

Abstract

Background: Administration of granulocyte colony-stimulating factors G-SCFs can cause diagnostic challenges because of morphologic alteration of hematopoietic cells.

Methods: We experienced a patient who showed distinctive clinical and morphologic findings after short time use of G-CSF. The clinical information and examination results of the morphology of bone marrow (BM) specimen and karyotype were analyzed by reviewing relevant literature.

Results: White blood cell (WBC) counts of the patient were unresponsive to G-CSF and marrow fibrosis and megakaryocytic hyperplasia were accompanied with increase of blasts in BM. Presence of malignant clones was confirmed by cytogenetic aberrations of monosomy 7.

Conclusions: We concluded, BM study including cytogenetic analysis should be performed when such clinical findings are encountered and the possibility of hematologic malignancy should be considered.

Publication types

  • Case Reports

MeSH terms

  • Bone Marrow*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Hyperplasia
  • Leukocytes
  • Primary Myelofibrosis*

Substances

  • Granulocyte Colony-Stimulating Factor